Wockhardt’s Zaynich gives new hope to cancer patient with successful liver transplant
Wockhardt's Zaynich antibiotic enables successful liver transplant for US cancer patient, shares soar, Phase III study nears ...
Why this pharma stock hit nearly 9-year high; froze at 10% upper circuit?
Wockhardt stock gained 10% to touch Rs 1,536.40; it has outperformed the market by zooming 262% thus far in calendar year ...
Wockhardt Share Zooms 10% To 52 Week High After Company's Antibiotic 'Zaynich' Successfully ...
Wockhardt's share price touched upper circuit level of 10 per on NSE (National Stock Exchange), after company's exchange ...
ET Now on MSN18 小时
Wockhardt Pharma share price jumps 10%, hits 9-year high - Here's why
Wockhardt Pharma shares hit the 10% upper circuit on Monday, December 16, reaching Rs 1,536.40—its highest level in nine ...
Pharmabiz20 小时
India needs new drugs, improve infection control practices to thwart AMR: Dr Prabhu Vinayagam
India needs new drugs, improve infection control practices to thwart AMR: Dr Prabhu Vinayagam: Nandita Vijayasimha Bengaluru Monday, December 16, 2024, 08:00 Hrs [IST] India needs ...
Medscape23 小时
Extended or Continuous Versus Short-term Intravenous Infusion of Cephalosporins
The following search terms were applied to all published articles: (cephalosporin or ceftriaxone or ceftazidime or cefotaxime or cefepime or ... occurring during antibiotic treatment were the ...